Acurx Pharmaceuticals, Inc. Reports Second Quarter 2026 results and provides business update Share Post Post navigation Previous PostNagarro Management Board and Supervisory Board recommend the acceptance of the voluntary public takeover offer by PersistentNext Post Avis Budget Group, Inc. Notice of September 29, 2026 Application Deadline for Class Action Lawsuit – Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline